ANDA 202509, held by Ph Health. Dutasteride; Tamsulosin Hydrochloride.
As of Nov 16, 2026, ANDA 202509 (Dutasteride And Tamsulosin Hydrochloride), held by Ph Health, was first approved by FDA on Feb 26, 2014, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 26, 2014 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dutasteride And Tamsulosin Hydrochloride0.5MG;0.4MG · capsule;oral | Dutasteride; Tamsulosin Hydrochloride | Discontinued |
| Apr 26, 2023 | Supplement 16Labeling · Standard review | Approved | None posted |
| Oct 23, 2020 | Supplement 11Labeling · Standard review | Approved | None posted |
| Feb 26, 2014 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters